Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Quest Diagnostics Incorporated stock (DGX)

Buy Quest Diagnostics Incorporated stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Quest Diagnostics Incorporated is a diagnostics & research business based in the US. Quest Diagnostics Incorporated shares (DGX) are listed on the NYSE and all prices are listed in US Dollars. Quest Diagnostics Incorporated employs 50,000 staff and has a trailing 12-month revenue of around $9.3 billion.

Our top picks for where to buy Quest Diagnostics Incorporated stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Best for beginners

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for cash sweep

Go to site
Advanced charts and trading tools
  • Trade stocks, ETFs and equity options without commission and $0 option contract fees
  • Earn up to 8.1% APY on your uninvested cash
  • Get a 1.5% match in cash on transferred assets up to $300 or up to 15 free fractional shares worth between $2 and $2,000

How to buy Quest Diagnostics Incorporated stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – DGX. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Quest Diagnostics Incorporated stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Choose a 1.5% match or up to 15 free fractional shares
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Quest Diagnostics Incorporated stock price (NYSE: DGX)

Use our graph to track the performance of DGX stocks over time.

Quest Diagnostics Incorporated shares at a glance

Information last updated 2024-07-07.
Latest market close$144.11
52-week range$117.60 - $145.62
50-day moving average $139.28
200-day moving average $132.47
Wall St. target price$147.46
PE ratio 18.9031
Dividend yield $2.88 (2.14%)
Earnings per share (TTM) $7.43

Is it a good time to buy Quest Diagnostics Incorporated stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Quest Diagnostics Incorporated price performance over time

Historical closes compared with the close of $144.11 from 2024-07-12

1 week (2024-07-05) 2.61%
1 month (2024-06-14) 4.54%
3 months (2024-04-12) 12.12%
6 months (2024-01-12) 6.51%
1 year (2023-07-14) 2.61%
2 years (2022-07-14) 8.17%
3 years (2021-07-14) 7.06%
5 years (2019-07-12) 45.84%

Is Quest Diagnostics Incorporated stock undervalued or overvalued?

Valuing Quest Diagnostics Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Quest Diagnostics Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Quest Diagnostics Incorporated's P/E ratio

Quest Diagnostics Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, Quest Diagnostics Incorporated shares trade at around 19x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Quest Diagnostics Incorporated's PEG ratio

Quest Diagnostics Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.5232. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Quest Diagnostics Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Quest Diagnostics Incorporated's EBITDA

Quest Diagnostics Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.8 billion.

The EBITDA is a measure of a Quest Diagnostics Incorporated's overall financial performance and is widely used to measure a its profitability.

Quest Diagnostics Incorporated financials

Revenue TTM $9.3 billion
Operating margin TTM 13.4%
Gross profit TTM $3.5 billion
Return on assets TTM 6.2%
Return on equity TTM 14.15%
Profit margin 9.11%
Book value $57.95
Market Capitalization $15.6 billion

TTM: trailing 12 months

Quest Diagnostics Incorporated share dividends


Dividend payout ratio: 33.52% of net profits

Recently Quest Diagnostics Incorporated has paid out, on average, around 33.52% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.14% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Quest Diagnostics Incorporated shareholders could enjoy a 2.14% return on their shares, in the form of dividend payments. In Quest Diagnostics Incorporated's case, that would currently equate to about $2.88 per share.

While Quest Diagnostics Incorporated's payout ratio might seem fairly standard, it's worth remembering that Quest Diagnostics Incorporated may be investing much of the rest of its net profits in future growth.

Quest Diagnostics Incorporated's most recent dividend payout was on 21 July 2024. The latest dividend was paid out to all shareholders who bought their shares by 7 July 2024 (the "ex-dividend date").

Have Quest Diagnostics Incorporated's shares ever split?

Quest Diagnostics Incorporated's shares were split on a 2:1 basis on 20 June 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Quest Diagnostics Incorporated shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Quest Diagnostics Incorporated shares which in turn could have impacted Quest Diagnostics Incorporated's share price.

Quest Diagnostics Incorporated share price volatility

Over the last 12 months, Quest Diagnostics Incorporated's shares have ranged in value from as little as $117.5989 up to $145.62. A popular way to gauge a stock's volatility is its "beta".

DGX.US volatility(beta: 0.88)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Quest Diagnostics Incorporated's is 0.881. This would suggest that Quest Diagnostics Incorporated's shares are less volatile than average (for this exchange).

Quest Diagnostics Incorporated overview

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. .

Frequently asked questions

What percentage of Quest Diagnostics Incorporated is owned by insiders or institutions?
Currently 0.437% of Quest Diagnostics Incorporated shares are held by insiders and 92.883% by institutions.
How many people work for Quest Diagnostics Incorporated?
Latest data suggests 50,000 work at Quest Diagnostics Incorporated.
When does the fiscal year end for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated's fiscal year ends in December.
Where is Quest Diagnostics Incorporated based?
Quest Diagnostics Incorporated's address is: 500 Plaza Drive, Secaucus, NJ, United States, 07094
What is Quest Diagnostics Incorporated's ISIN number?
Quest Diagnostics Incorporated's international securities identification number is: US74834L1008
What is Quest Diagnostics Incorporated's CUSIP number?
Quest Diagnostics Incorporated's Committee on Uniform Securities Identification Procedures number is: 74834L100

More guides on Finder

Ask a Question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site